Cargando…
Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients
PURPOSE: To better understand the pathophysiological mechanisms underlying neuromyelitis optica (NMO), we developed a proteomics platform for biomarker discovery in the cerebrospinal fluid (CSF) of patients with NMO. METHODS: Two-dimensional electrophoresis (2-DE) and matrix-assisted laser desorptio...
Autores principales: | Bai, Shumei, Liu, Shilian, Guo, Xuxiao, Qin, Zhaoyu, Wang, Banqin, Li, Xiaohong, Qin, Yanjiang, Liu, Yi-Hsin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730746/ https://www.ncbi.nlm.nih.gov/pubmed/19710940 |
Ejemplares similares
-
Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis
por: Liu, Shilian, et al.
Publicado: (2009) -
Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica
por: Guo, Yong, et al.
Publicado: (2017) -
Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder
por: Yamashita, Kazuya, et al.
Publicado: (2018) -
Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks
por: Sato, Douglas Kazutoshi, et al.
Publicado: (2014) -
Detection of mumps virus RNA in cerebrospinal fluid of patients with neuromyelitis optica
por: Mori, Masahiro, et al.
Publicado: (2011)